N/A
N=92
The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions
Post-operative Complications · Surgical Site Infection · Surgical Wound Infection
Bottom Line
View on ClinicalTrials.gov: NCT01450631 ↗Enrolled (actual)
92
Serious AEs
6.5%
Results posted
Aug 2014
Primary outcome: Primary: Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. — 7; 2 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Prevena™ Incision Management System (PIMS) (Device); Standard-of-care Dressing (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- KCI USA, Inc
- Primary completion
- Dec 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. |
7; 2 | — |
| SECONDARY Incidence Rate of Surgical Incision Intervention (SII) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. |
6; 1 | — |
Summary
The purpose of this study is to compare the post-surgical standard-of-care dressing to the Prevena™ Incision Management System in women undergoing Cesarean section surgery.
Eligibility Criteria
Inclusion Criteria
The Subject:
- is a female aged ≥ 18 years
- is able to provide her own informed consent
- will undergo a Cesarean section procedure using a subcuticular skin closure technique within the next 42 days
- will require a surgical incision able to be covered completely by the PIMS skin interface
- has a BMI ≥ 35 kg/m2 as determined during the Screening Period up to 42 days pre-surgery
- is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
- Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered
- OR -
- Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination
- is willing and able to return for all scheduled and required study visits
- is not concurrently enrolled in another clinical intervention trial which may impact maternal health or the surgical site
Exclusion Criteria
The Subject:
- is ASA Class P4, P5, or P6 (Appendix F - American Society of Anesthesiologists (ASA) Physical Status Classification System)
- has a systemic bacterial or fungal infection at the time of surgery
- has a remote-site skin infection at the time of surgery
- has a life expectancy of < 12 months
- is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
- Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
- Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
- experiences intraoperative hemorrhage requiring transfusion, disseminated-intravascular coagulopathy (DIC) or other medical or surgical condition during the Cesarean section deemed by the investigator to pose a prohibitively high risk for surgical re-exploration
- who, in the investigator's opinion, would have any clinically significant condition that would impair the participant's ability to comply with the study procedures
- has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
Data sourced from ClinicalTrials.gov (NCT01450631). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.